ARCHIVES

FDA Proposes “Clarification” Of Clinical Studies regulations, Including Sanctions, Inspections

This article is from The Cancer Letter archive.

Vol. 04 No. 33 | August 18, 1978

Download PDF Visit The Full Archive

Related Articles

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

February 17, 2006

Tobacco Council Awards New Grants

April 18, 1980

Advances Found In Treatment Of Aerodigestive Cancers

May 25, 2001

Healy’s “Save Bob” Campaign

January 6, 1995

BMS Control Of Billion-Dollar Taxol Market Facing Court Challeges By Competitors

May 29, 1998

ACS Asks $1.5 Billion for NCI; Waxman Considers Requiring NIH To Send Budget Directly To Congress

March 4, 1983